Bastion Asset Management Inc. Buys Shares of 451,159 AdaptHealth Corp. $AHCO

Bastion Asset Management Inc. purchased a new position in AdaptHealth Corp. (NASDAQ:AHCO) in the 3rd quarter, Holdings Channel reports. The institutional investor purchased 451,159 shares of the company’s stock, valued at approximately $4,199,000. AdaptHealth comprises approximately 2.4% of Bastion Asset Management Inc.’s investment portfolio, making the stock its 16th biggest holding.

Several other institutional investors have also modified their holdings of the business. AlphaQuest LLC increased its stake in AdaptHealth by 275.7% during the 2nd quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock worth $37,000 after purchasing an additional 2,892 shares in the last quarter. Assetmark Inc. boosted its holdings in shares of AdaptHealth by 87.6% in the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock valued at $52,000 after buying an additional 2,581 shares during the period. Tower Research Capital LLC TRC increased its position in shares of AdaptHealth by 318.0% during the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares in the last quarter. Tidal Investments LLC acquired a new stake in shares of AdaptHealth during the second quarter worth $96,000. Finally, CWM LLC raised its holdings in shares of AdaptHealth by 1,562.1% during the second quarter. CWM LLC now owns 10,471 shares of the company’s stock worth $99,000 after acquiring an additional 9,841 shares during the period. Institutional investors own 82.67% of the company’s stock.

Insider Transactions at AdaptHealth

In other AdaptHealth news, Director David Solomon Williams III sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average price of $9.43, for a total value of $47,150.00. Following the completion of the transaction, the director directly owned 45,045 shares in the company, valued at $424,774.35. This trade represents a 9.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.55% of the company’s stock.

AdaptHealth Trading Up 1.1%

Shares of NASDAQ:AHCO opened at $10.20 on Monday. The company’s 50-day moving average price is $10.24 and its two-hundred day moving average price is $9.63. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.63. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.08 and a quick ratio of 0.86. The stock has a market capitalization of $1.38 billion, a PE ratio of 18.55, a price-to-earnings-growth ratio of 1.16 and a beta of 1.72.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AHCO. Weiss Ratings raised shares of AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 30th. Canaccord Genuity Group boosted their price target on AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Zacks Research upgraded AdaptHealth from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Finally, Wall Street Zen lowered AdaptHealth from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $14.25.

AdaptHealth Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.